Liminatus Pharma, Inc. - Class A Common Stock (LIMN)
1.2900
-0.3000 (-18.87%)
NASDAQ · Last Trade: Sep 18th, 5:20 PM EDT
Detailed Quote
Previous Close | 1.590 |
---|---|
Open | 1.450 |
Bid | 1.290 |
Ask | 1.300 |
Day's Range | 1.240 - 1.450 |
52 Week Range | 1.580 - 33.66 |
Volume | 2,207,201 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 2,417,934 |
Chart
News & Press Releases
Via Benzinga · September 18, 2025
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · September 18, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · August 22, 2025
Via Benzinga · August 22, 2025
Via Benzinga · August 21, 2025
Liminatus Identifies BNB Coin as Its Primary Strategic Target for Digital Asset Allocation, with Plans to Aggressively Accumulate and Hold Up to $500 Million for Long-Term Strategic Value
By Liminatus Pharma Inc. · Via GlobeNewswire · July 28, 2025
Strategic Internal Review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committed
By Liminatus Pharma Inc. · Via GlobeNewswire · July 25, 2025
Via Benzinga · July 24, 2025
Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing paths
By Liminatus Pharma Inc. · Via GlobeNewswire · July 24, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · July 24, 2025
Via Benzinga · July 24, 2025
Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficiency while maintaining core focus on immunotherapy innovation
By Liminatus Pharma Inc. · Via GlobeNewswire · July 22, 2025
Via Benzinga · July 17, 2025
Via Benzinga · July 10, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 3, 2025
U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.
Via Benzinga · July 2, 2025
Via Benzinga · June 30, 2025
Via Benzinga · June 26, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 25, 2025